PolyNovo Limited Stock
Stocks
PNV
AU000000PNV0
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Australian S.E.
02:11:02 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 1.040 AUD | +0.97% |
|
0.00% | -15.45% |
| 08-27 | Bell Potter Upgrades PolyNovo to Buy from Hold; Price Target is AU$1.22 | MT |
| 08-26 | PolyNovo Limited, 2026 Earnings Call, Aug 26, 2026 |
| Market Cap | 718M 519M 446M 419M 383M 716M 49.05B 4.97B 1.92B 25.12B 1.95B 1.9B 80B | P/E 2027 * |
73.8x | P/E 2028 * | 35.4x |
|---|---|---|---|---|---|
| Enterprise Value | 678M 490M 421M 396M 361M 676M 46.3B 4.69B 1.81B 23.71B 1.84B 1.8B 75.52B | EV / Sales 2027 * |
4.19x | EV / Sales 2028 * | 3.56x |
| Free-Float |
88.97% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PNV | Delayed | |
Tradegate
| MFJ | Real-time | |
|
OTC Markets
| CALZF | Delayed | |
|
Deutsche Boerse AG
| MFJ | Delayed | |
|
Börse Stuttgart
| MFJ | Delayed | |
|
Boerse Muenchen
| MFJ | Real-time | |
|
Berne S.E.
| MFJ | End-of-day quote |
Last Transcript : PolyNovo Limited
| 25-08-25 | Morgans rates PNV as Speculative Buy | AQ |
| 24-11-25 | Morgans rates PNV as Add | AQ |
| 23-12-07 | Ord Minnett rates PNV as Lighten | AQ |
| 22-04-22 | PolyNovo : Notification regarding unquoted securities - PNV | PU |
| 22-01-23 | PolyNovo : Application for quotation of securities - PNV | PU |
| 1 day | +0.97% | ||
| Current month | +3.48% | ||
| 1 month | +18.86% | ||
| 3 months | -1.42% | ||
| 6 months | +10.64% | ||
| Current year | -15.45% |
| 1 week | 0.98 |  | 1.07 |
| 1 month | 0.88 | | 1.17 |
| Current year | 0.81 | | 1.3 |
| 1 year | 0.81 | | 1.66 |
| 3 years | 0.81 | | 2.78 |
| 5 years | 0.81 | | 2.78 |
| 10 years | 0.17 | | 4.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Peatey
CEO | Chief Executive Officer | - | 2025-11-30 |
| Director of Finance/CFO | - | 2018-12-11 | |
Marthe D’Ombrain
CTO | Chief Tech/Sci/R&D Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Leon Hoare
CHM | Chairman | - | 2025-10-26 |
Robyn Elliott
BRD | Director/Board Member | 65 | 2019-10-27 |
| Director/Board Member | - | 2020-05-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/16/26 | Buy | Director | 151,000 | 0.0219% | ||
| 2/27/26 | Buy | Director | 100,000 | 0.0145% | ||
| 2/27/26 | Buy | Chairman | 30,000 | 0.0043% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | 0.00% | -31.80% | -21.51% | 513M | |
| -0.42% | -3.68% | -18.51% | +6.67% | 187B | |
| +1.15% | +3.22% | +1.37% | +16.68% | 120B | |
| -1.86% | +2.77% | +13.15% | +89.47% | 63.15B | |
| +0.02% | -1.07% | +17.69% | +45.19% | 51.75B | |
| -1.54% | -2.52% | -3.98% | -30.72% | 50.32B | |
| -2.02% | -3.22% | +9.18% | -17.76% | 33.17B | |
| 0.00% | +3.71% | - | - | 32.1B | |
| -0.81% | +0.74% | +35.59% | -16.03% | 23.93B | |
| -2.41% | -6.52% | -10.28% | +8.53% | 22.99B | |
| Average | -0.69% | -0.52% | +1.38% | +8.95% | 58.58B | |
| Weighted average by Cap. | -0.47% | -0.64% | -1.55% | +16.10% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 162M 117M 100M 94.45M 86.22M 161M 11.04B 1.12B 433M 5.66B 439M 429M 18.01B | 186M 134M 115M 108M 98.92M 185M 12.67B 1.28B 497M 6.49B 503M 492M 20.67B |
| Net income | 9.77M 7.05M 6.07M 5.71M 5.21M 9.74M 667M 67.65M 26.15M 342M 26.49M 25.91M 1.09B | 20.34M 14.68M 12.62M 11.87M 10.84M 20.27M 1.39B 141M 54.42M 711M 55.13M 53.92M 2.26B |
| Net Debt | -40.27M -29.06M -25M -23.51M -21.46M -40.14M -2.75B -279M -108M -1.41B -109M -107M -4.48B | -57.04M -41.17M -35.41M -33.3M -30.4M -56.86M -3.89B -395M -153M -1.99B -155M -151M -6.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-07 | A$1.040 | +0.97% | 3,344,262 |
| 26-09-04 | A$1.030 | +0.98% | 1,206,616 |
| 26-09-03 | A$1.020 | +2.00% | 1,643,444 |
| 26-09-02 | A$1.000 | -0.50% | 1,538,028 |
| 26-09-01 | A$1.005 | 0.00% | 1,182,114 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PNV Stock
Select your edition
All financial news and data tailored to specific country editions
